CTOR Citius Oncology, Inc. - Common Stock
$0.81
价格 · 五月 20, 2026
截至...的财报数据 五月 15, 2026
CTOR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.81
市值
$170M
P/E (TTM)
-6.0
每股收益 (TTM)
$-0.34
营收 (TTM)
—
股息收益率
—
ROE
-61.5%
负债/权益
—
52周区间
$0 – $6
CTOR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-0.34
2022-12-31
→
2025-09-30
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
指标
5年趋势
CTOR
同行中位数
P/E (TTM)
-6.0
—
P/B (市净率)
3.8
1.5
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CTOR
同行中位数
ROA
-26.7%
-43.7%
ROE
-61.5%
-62.7%
ROIC
-54.8%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CTOR
同行中位数
Current Ratio (流动比率)
0.6
5.7
Quick Ratio (速动比率)
0.1
—
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CTOR
同行中位数
EPS YoY
125.0%
—
Net Income YoY (净利润同比增长)
535.3%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CTOR
同行中位数
CTOR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-05-18
最低
$6.00
最高
$6.00
中位数目标
$6.00
+645.2%
平均目标
$6.00
+645.2%
收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
平均惊喜
-0.28%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.43 | $-0.01 | — |
| 2026年3月31日 | $-1.43 | $-0.01 | -1.4% |
| 2025年12月31日 | $-0.06 | $0.06 | -0.12% |
| 2025年9月30日 | $-0.06 | $-0.12 | 0.06% |
| 2025年6月30日 | $-0.08 | $-0.15 | 0.07% |
| 2025年3月31日 | $-0.11 | $-0.09 | -0.02% |
同行比较 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | — |
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
| ACRV | $76M | -1.2 | — | — | -61.0% | — |
| ACET | $81M | -0.5 | — | — | -79.8% | — |
| XBIT | — | -1.6 | — | — | — | — |
| GANX | $135M | -5.3 | -60.6% | — | -181.1% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $5M | · | $4M | · | · | |
| SG&A Expense | $9M | $8M | $1M | $6M | $138.1K | $10.1K | |
| Operating Expenses | $24M | $21M | · | $12M | · | · | |
| Operating Income | $-24M | $-21M | $-1M | · | $-138.1K | $-10.1K | |
| Interest Expense | $218.0K | · | · | · | · | · | |
| Interest Income | $36.4K | · | · | · | · | · | |
| Other Non-op | $-181.7K | · | $3M | · | $518.9K | · | |
| Pretax Income | $-24M | $-21M | · | $-12M | · | · | |
| Income Tax | $1M | $576.0K | · | $576.0K | · | · | |
| Net Income | $-25M | $-21M | $2M | $-13M | $380.8K | $-10.1K | |
| EPS (Basic) | $-0.34 | $-0.31 | $0.27 | $-0.19 | $0.12 | $-0.01 | |
| EPS (Diluted) | $-0.34 | $-0.31 | $0.27 | $-0.19 | $0.12 | · | |
| Shares (Basic) | 73,267,969 | 68,053,607 | 6,600,000 | 67,500,000 | 1,341,758 | 1,725,000 | |
| Shares (Diluted) | 73,267,969 | 68,053,607 | 6,600,000 | 67,500,000 | 1,341,758 | · | |
| EBITDA | $-24M | · | $-1M | · | $-138.1K | · |
资产负债表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $112 | $32.7K | · | $289.2K | · | |
| Inventory | $22M | $8M | · | · | · | · | |
| Prepaid Expense | $1M | $3M | $25.5K | $8M | $88.2K | · | |
| Current Assets | $28M | $11M | $58.2K | $8M | $377.3K | $126.4K | |
| Total Assets | $101M | $84M | $73M | $48M | $68M | $126.4K | |
| Accounts Payable | $13M | $4M | · | $1M | · | · | |
| Accrued Liabilities | $4M | · | $375.9K | $259.1K | · | · | |
| Short-term Debt | · | · | $1M | · | · | · | |
| Current Liabilities | $49M | $33M | $2M | $21M | $31.8K | $136.5K | |
| Deferred Tax | $3M | $2M | · | $1M | · | · | |
| Total Liabilities | $56M | $38M | · | $22M | · | · | |
| Common Stock | $8.4K | $7.2K | $167 | $6.8K | $242 | $173 | |
| Paid-in Capital | $109M | $85M | · | $44M | · | $24.8K | |
| Retained Earnings | $-64M | $-39M | $-2M | $-18M | $345.3K | $-10.1K | |
| Stockholders' Equity | $45M | $46M | $23M | $26M | $345.5K | $-10.1K | |
| Liabilities + Equity | $101M | $84M | $73M | $48M | $68M | $126.4K | |
| Shares Outstanding | 83,513,442 | 71,552,402 | 2,341,000 | 67,500,000 | 2,416,000 | 2,416,000 |
现金流 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $7M | · | $2M | · | · | |
| Deferred Tax | $1M | $576.0K | · | $576.0K | · | · | |
| Operating Cash Flow | $-5M | $126.4K | $-601.3K | · | $-48.0K | · | |
| Investing Cash Flow | $-6M | $-5M | $-1M | · | $-67M | · | |
| Stock Issued | $15M | · | · | · | $66M | · | |
| Net Stock Activity | $15M | · | · | · | $66M | · | |
| Financing Cash Flow | $15M | $5M | $2M | · | $68M | · | |
| Net Change in Cash | · | · | $-256.4K | · | $289.2K | · |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| ROA | -26.7% | · | 4.0% | · | 1.1% | · | |
| ROE | -61.5% | · | 20.5% | · | 2.1% | · | |
| ROIC | -54.8% | · | · | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | · | 0.0 | · | 11.9 | · | |
| Quick Ratio | 0.1 | · | 0.0 | · | 9.1 | · | |
| Interest Coverage | -107.9 | · | · | · | · | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| EPS YoY | · | · | 125.0% | · | · | · | |
| Net Income YoY | · | · | 535.3% | · | · | · |
估值 (TTM) 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-25M | $-21M | $2M | · | $380.8K | · | |
| Market Cap | $170M | · | $26M | · | $25M | · | |
| P/E | -6.0 | -4.5 | 40.5 | · | 84.7 | · | |
| P/B | 3.8 | · | -12.9 | · | 71.0 | · | |
| P / Tangible Book | 3.8 | 2.2 | 1.1 | · | 71.0 | · | |
| P / Cash Flow | -30.9 | · | -42.6 | · | -511.7 | · | |
| Earnings Yield | -16.8% | -22.3% | 2.5% | · | 1.2% | · |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $2M | $4M | |
| Cost of Revenue | $328.9K | $789.2K | |
| Gross Profit | $1M | $3M | |
| R&D Expense | $1M | $1M | |
| SG&A Expense | $24M | $3M | |
| Operating Expenses | $30M | $8M | |
| Operating Income | $-29M | $-5M | |
| Interest Income | $43.7K | $28.3K | |
| Other Non-op | $2M | $-17.6K | |
| Pretax Income | $-27M | $-5M | |
| Income Tax | $-231.2K | $264.2K | |
| Net Income | $-27M | $-6M | |
| EPS (Basic) | $-0.27 | $-0.06 | |
| EPS (Diluted) | $-0.27 | $-0.06 | |
| Shares (Basic) | 100,027,204 | 87,462,385 | |
| Shares (Diluted) | 100,027,204 | 87,462,385 | |
| EBITDA | $-29M | $-5M |
资产负债表 17
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $3M | $7M | |
| Receivables | $1M | $4M | |
| Inventory | $23M | $23M | |
| Prepaid Expense | $3M | $3M | |
| Current Assets | $29M | $37M | |
| Total Assets | $101M | $110M | |
| Accounts Payable | $9M | $10M | |
| Accrued Liabilities | $24M | $5M | |
| Current Liabilities | $59M | $45M | |
| Deferred Tax | $3M | $3M | |
| Total Liabilities | $65M | $52M | |
| Common Stock | $9.3K | $8.5K | |
| Paid-in Capital | $131M | $128M | |
| Retained Earnings | $-96M | $-70M | |
| Stockholders' Equity | $35M | $58M | |
| Liabilities + Equity | $101M | $110M | |
| Shares Outstanding | 92,981,204 | 84,797,846 |
现金流 7
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Stock-based Comp | $4M | $4M | |
| Deferred Tax | $-231.2K | $264.2K | |
| Operating Cash Flow | $-4M | $-7M | |
| Investing Cash Flow | $-600.0K | $-4M | |
| Stock Issued | $-61.9K | $15M | |
| Net Stock Activity | · | $15M | |
| Financing Cash Flow | $-231.2K | $15M |
盈利能力 8
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Gross Margin | 80.3% | 80.0% | |
| Operating Margin | -1716.2% | -133.2% | |
| Net Margin | -1596.0% | -140.3% | |
| Pretax Margin | -1609.8% | -133.6% | |
| EBITDA Margin | -1716.2% | -133.2% | |
| ROA | -27.7% | -5.5% | |
| ROE | -75.0% | -11.1% | |
| ROIC | -80.4% | -9.4% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 0.5 | 0.8 | |
| Quick Ratio | 0.1 | 0.3 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | |
| Receivables Turnover | 3.1 | 1.9 |
估值 (TTM) 7
| 指标 | 趋势 | Q2 2026 | Q1 2025 |
|---|---|---|---|
| Net Income TTM | $-45M | $-25M | |
| Market Cap | $58M | $85M | |
| P/E | -1.2 | -2.9 | |
| P/B | 1.6 | 1.5 | |
| P / Tangible Book | 1.6 | 1.5 | |
| P / Cash Flow | · | -11.5 | |
| Earnings Yield | -83.9% | -34.0% |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-09-30 | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 净收入 | $-25M | $-21M | $2M | $-13M | $380.8K |
| 稀释后每股收益 (EPS) | $-0.34 | $-0.31 | $0.27 | $-0.19 | $0.12 |
资产负债表
| 2025-09-30 | 2024-09-30 | 2023-12-31 | 2023-09-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 0.6 | — | 0.0 | — | 11.9 |
| 速动比率 | 0.1 | — | 0.0 | — | 9.1 |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。